Physician profile
John A King
NPI 1609850833
$2,978.52
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $323 · 2021: $735 · 2022: $652 · 2023: $535 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.81 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $550.19 | 2019-2023 | |
| Pfizer INC. | $341.09 | 2019-2024 | |
| Therapeuticsmd, INC. | $275.90 | 2019-2022 | |
| Organon LLC | $184.84 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $175.05 | 2022-2024 | |
| Cumberland Pharmaceuticals, INC. | $163.53 | 2022-2023 | Caldolor |
| Myovant Sciences INC. | $153.94 | 2021-2022 | |
| Avanos Medical | $148.37 | 2019 | |
| Evofem Biosciences, INC. | $137.08 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.19 | 2020-2024 | |
| Coopersurgical, INC. | $115.99 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Exeltis, USA INC. | $95.45 | 2022-2024 | Slynd, Nuvessa |
| Astellas Pharma US INC | $57.94 | 2023-2024 | Veozah |
| Dysis Medical, INC. | $57.15 | 2020 | |
| Agile Therapeutics, INC. | $54.34 | 2021-2023 | Twirla |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $49.02 | 2019 | |
| Lupin INC. | $43.27 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $42.50 | 2023 | Myfembree |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Merck Sharp & Dohme LLC | $35.07 | 2020 | |
| Avion Pharmaceuticals | $35.05 | 2021-2022 | |
| Medicem INC. | $28.98 | 2021 | |
| Convatec INC. | $18.41 | 2022 | |
| Hologic Sales and Service, LLC | $18.31 | 2022 | |
| Exact Sciences Corporation | $18.07 | 2024 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $15.79 | 2023 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.